Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05708092
Other study ID # STUDY-21-00561
Secondary ID 2020-75-CX-0007
Status Recruiting
Phase N/A
First received
Last updated
Start date March 22, 2022
Est. completion date December 2025

Study information

Verified date May 2024
Source Icahn School of Medicine at Mount Sinai
Contact Annell Ovalles, MPH
Phone 212-241-4706
Email annell.ovalles@mountsinai.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the effectiveness of NeuroResource Facilitation, a novel/innovative intervention, in reducing recidivism in offenders with brain injury (BI).


Description:

The prevalence of brain injury (BI) is significantly greater in justice-involved populations, and a substantial proportion of prisoners have likely experienced a BI during their lifetime. A history of BI has a statistically significant association with increased use of correctional, medical and psychological services including crisis intervention; an increased frequency of institutional misconducts; and higher recidivism rates. Brain injury in justice-involved populations is frequently undiagnosed, and therefore untreated, which contributes to the cycle of recidivism. Identifying BI opens up new resources to ex- offenders that can more effectively help them to become productive in their lives in the community. In partnership with the Icahn School of Medicine at Mount Sinai, the Brain Injury Association of Pennsylvania, and the Pennsylvania Department of Corrections (PADOC), this project will implement a randomized clinical trial to determine if a case management intervention called Neurorehabilitation Facilitation (NRF) is effective in reducing recidivism by ten percent in offenders with acquired BI. Offenders in two Pennsylvania prisons (State Correctional Institution (SCI) sites in PA, SCI Phoenix, SCI Chester, SCI Frackville, and SCI Mahanoy) will be screened for BI and cognitive impairment, and those who screen positive will be randomized to receive the intervention or to receive standard of care (SoC). Two thirds of those randomized will receive the intervention and the remaining one third will serve as controls. All participants will be followed for up to three years following their release to examine the immediate and long-term reduction in recidivism. The primary hypothesis is that NRF, as compared to SoC, will result in a 10% reduction in average 1-year recidivism, estimated by the 2013 Department of Corrections (DOC) report as 35-38%. Understanding that additional factors will contribute to the effect of NRF, the required sample was based on the primary analysis, a logistic regression of the binary response variable recidivism, adjusted for additional independent variables (described below) in the model with estimated R-squared=0.10. An effect size of 10% reduction corresponds to an odds ratio in this model of 0.643. With two thirds (67%) of cases randomized to NRF, and one third (33%) randomized to SoC, a total sample of N=688 provides 80% power at alpha set at 0.05. Anticipating that there will be a loss of approximately 10% of randomized cases to attrition, N=764 cases will be randomized, with n=509 cases randomized to NRF and 255 randomized to SoC.


Recruitment information / eligibility

Status Recruiting
Enrollment 765
Est. completion date December 2025
Est. primary completion date December 2025
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria: - 18+ years old - Proficient in English - History of brain injury (OSU-TBI-ID) - Significant cognitive impairment (RBANS and Trails A&B) - Within 6 months of release - Returning to 6 county area (Bucks, Chester, Delaware, Montgomery, Philadelphia and Schuylkill) Exclusion Criteria: - Non-English Speaking - Under 18 years old

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
NeuroResource Facilitation (NRF)
NRF is defined as a specialized service that promotes access to services and coordinates care specific to the needs of individuals with brain injury. Possible resources include vocational services, medical assistance, Social Security (SSI or SSDI if appropriate), and other organizations that can support reentry. If needed to gain access to services and organizations, the facilitator will also provide participants with a summary that includes results from brain injury screenings questionnaire, neurocognitive (thinking abilities) tests, and symptoms. The researchers will share information and coordinate with prison and parole staff about participation in the study. Participant's information will also be shared with resources that could help participants after release, such as funding sources and brain injury services. After release from SCI, the NRF facilitator will assist the participant with all the preparation and logistics associated with the resources the participant applied to.

Locations

Country Name City State
United States Brain Injury Association of Pennsylvania Carlisle Pennsylvania
United States Icahn School of Medicine at Mount Sinai New York New York

Sponsors (2)

Lead Sponsor Collaborator
Icahn School of Medicine at Mount Sinai Brain Injury Association of Pennsylvania

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Recidivism According to the PADOC, rearrest is measured as the first instance of arrest after inmates are released from state prison and reincarceration is measured as the first instance of returning to state prison after an offender is released from state prison.
Overall recidivism is measured as the first instance of any type of rearrest or reincarceration after inmates are released from state prison.
at year 1
Primary Number of Recidivism According to the PADOC, rearrest is measured as the first instance of arrest after inmates are released from state prison and reincarceration is measured as the first instance of returning to state prison after an offender is released from state prison.
Overall recidivism is measured as the first instance of any type of rearrest or reincarceration after inmates are released from state prison.
at year 3
Secondary Number of Productive Activities Hours Productive Activities Hours include competitive employment (hours worked), and volunteer work (hours worked), brain injury clubhouses (hours attended), vocational training program (hours attended), and education (hours attended). up to 36 months post release
Secondary Number or Participants Engaged in Productive Activity The number of participants who engage in vocational training program or education activity at end of program. up to 36 months post release
Secondary Number of Participants Engaged with Services Engagement with Services. Engagement with Services includes community-based specialized NeuroRehabilitation services (physical therapy, occupational therapy, speech therapy, cognitive rehabilitation therapy, neuropsychology), and vocational rehabilitation services (job development, job placement, job coaching). up to 36 months post release
Secondary Number of Participants Connected to Health/Medical Resources The connection to Health/Medical resources will also be measured, "safety net" resources (SNAP, MA, SSI, food bank, etc). up to 36 months post release
Secondary Number of participants in Community Support Community Support - Participation in support groups and recovery resources, including religious activities, recreation, and access to transportation. up to 36 months post release
Secondary Number of Participants in Stable Housing Community Support - whether the ex-offender has stable housing up to 36 months post release
Secondary Number of Parole Obligations Met Parole Obligations - the extent to which the ex- offender has satisfied the obligations of Parole will be tracked, such as whether they have completed all mandated treatment up to 36 months post release
Secondary Number of Participants Discharged from Supervision Number of participants that have been or (are likely to be) discharged from supervision. up to 36 months post release
Secondary Date of Reception The day on which an individual was initially received into the custody up to 36 months post release
Secondary Date Committed The day on which an individual was committed to sentenced up to 36 months post release
Secondary Date of entry into Department of Corrections The day on which an individual was admitted into the Department of Corrections up to 36 months post release
Secondary Number of Participants with particular Classification of Offense Number of Participants with particular Classification of Offense as listed by the Department of Corrections up to 36 months post release
Secondary Number of participants who are Guilty but mentally ill Number of participants who are guilty but mentally ill up to 36 months post release
Secondary Number of Participants Recommended for aftercare Number of Participants Recommended to receive aftercare up to 36 months post release
Secondary Status of Participants after Program completion Status of Participants after Program completions as determined by the Department of Corrections up to 36 months post release
Secondary Program category Program category as as determined by the Department of Corrections up to 36 months post release
See also
  Status Clinical Trial Phase
Completed NCT02710123 - Sub-Threshold Exercise Treatment for Adolescents With Sports Related Concussion N/A
Recruiting NCT02777060 - Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures N/A
Completed NCT02262286 - MIND (Management of Traumatic Brain Injury Diagnosis) N/A
Completed NCT01461902 - Vasospasm in Pediatric Traumatic Brain Injury N/A
Recruiting NCT01198964 - Optimization of Human Cortical Stimulation
Active, not recruiting NCT01207050 - Effect of Rozerem on Sleep Among People With Traumatic Brain Injury Phase 4
Completed NCT00875329 - Traumatic Brain Injury (TBI) Screening Instruments N/A
Completed NCT01201863 - Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy Phase 4
Completed NCT01059890 - Cerebral Antibiotics Distribution After Acute Brain Injury Phase 1
Completed NCT01035606 - Training in Goal-directed Attention Regulation for Individuals With Brain Injury N/A
Completed NCT00596765 - Neuropsychological Cognitive Behavioral Therapy for Patients With Acquired Brain Injury N/A
Completed NCT00571623 - Automated Chest Physiotherapy to Improve Outcomes in Neuro N/A
Completed NCT00336466 - The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS) Phase 2
Recruiting NCT05105763 - Biofeedback Gait Retraining for Stiff Knee Gait Correction N/A
Recruiting NCT02495558 - Cough Assessment in Patients With Severe Acquired Brain Injury N/A
Completed NCT02100592 - Early Verticalization in neuroICU With ERIGO: a Safety and Feasibility Study Phase 1/Phase 2
Completed NCT00797680 - Duration of Hypothermia for Neuroprotection After Pediatric Cardiac Arrest Phase 2
Completed NCT00018499 - Genotype Influence on Recovery After Traumatic Brain Injury N/A
Recruiting NCT02567201 - Electrophysiological Evaluation of Voluntary Attention N/A
Withdrawn NCT05581927 - Whole-Body Hypothermia for Neonates With Hypoxic-Ischemic Encephalopathy(HIE) N/A